Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Isagro share sale clarification

Italian agrochemical company Isagro (Milan) has sold over 99% of its entire offer of new ordinary and growth shares. That includes €15.9 million ($21.6 million) from the company’s controlling system and €13.1 million ($17.8 million) on the stock market through an offer in option to the shareholders of Isagro, and not just the former as reported last month (Agrow No 688, p 3). The remaining unsubscribed 0.77% of the planned sale has been offered on the Italian stock exchange. The capital increase through the issue of new shares was concluded on May 21st after Agrow went to press. Holding company Holdisa has not diluted its controlling stake in Isagro, with the new shares carrying no voting rights, the company says. Should Holdisa’s stake fall below 50% of Isagro (currently 55%) the offered “growth shares” would convert into ordinary shares, and in the event of a “compulsory public offer” would carry a 20% dividend over ordinary shares.

Advertisement
Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG002019

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel